Sargent Bickham Lagudis LLC Invitae Corp Transaction History

Sargent Bickham Lagudis LLC

  • $1.22 Billion
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$24.31 - $33.6 $4,862 - $6,720
-200 Closed
0 $0
Q1 2021

May 24, 2021
SELL
$33.06 - $56.93 $8,529 - $14,687
-258 Reduced 56.33%
200 $8,000
Q4 2020

May 24, 2021
BUY
$39.09 - $57.4 $10,085 - $14,809
258 Added 129.0%
458 $19,000
Q3 2020

Sep 01, 2021
BUY
$28.43 - $44.67 $5,686 - $8,934
200 New
200 $9,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email